Crossmark

Risk stratification of cardiac metastases using late gadolinium enhancement cardiovascular magnetic resonance: prognostic impact of hypo-enhancement evidenced tumor avascularity

Crossref DOI link: https://doi.org/10.1186/s12968-021-00727-2

Published Print: 2021-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Chan, Angel T.

Dinsfriend, William

Kim, Jiwon

Yum, Brian

Sultana, Razia

Klebanoff, Christopher A.

Plodkowski, Andrew

Perez Johnston, Rocio

Ginsberg, Michelle S.

Liu, Jennifer

Kim, Raymond J.

Steingart, Richard

Weinsaft, Jonathan W. https://orcid.org/0000-0002-8386-0297
Funding

Funding for this research was provided by:

Memorial Sloan-Kettering Cancer Center (P30 CA008748)

American Heart Association (18CDA34080090)

National Institutes of Health (K23HL140092, R01HL128278)
License Information

Text and Data Mining valid from 2021-03-01

Text and Data Mining valid from 2021-03-01

Version of Record valid from 2021-04-05
More Information

This article is maintained by: Elsevier

Article Title: Risk stratification of cardiac metastases using late gadolinium enhancement cardiovascular magnetic resonance: prognostic impact of hypo-enhancement evidenced tumor avascularity

Journal Title: Journal of Cardiovascular Magnetic Resonance

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s12968-021-00727-2

Content Type: article

Copyright: Copyright © 2021 THE AUTHORS. Published by Elsevier Inc on behalf of the Society for Cardiovascular Magnetic Resonance

Document is current

Any future updates will be listed below